Discgenics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-11-06
- Employees
- 11
- Market Cap
- -
- Website
- http://www.discgenics.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration
Phase 1
Completed
- Conditions
- Degenerative Disc Disease
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- DiscGenics, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT03955315
- Locations
- 🇯🇵
Chiba University Hospital, Chuo-ku, Chiba Prefecture, Japan
🇯🇵Tokai University Hospital, Isehara, Kanagawa Prefecture, Japan
🇯🇵Mie University Hospital, Tsu city, Mie, Japan
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Phase 1
Completed
- Conditions
- Degenerative Disc Disease
- Interventions
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- DiscGenics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03347708
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸UC San Diego CIRM Alpha Stem Cell Clinic, San Diego, California, United States
News
No news found